Definitive Healthcare Corp. Class A (DH)

Over the past six months, Definitive Healthcare Corp.'s stock price has experienced a decline, reaching $2.60 as of November 20, 2025. Key events impacting the stock include Q1, Q2, and Q3 2025 earnings reports, the Annual General Meeting, and the Morgan Stanley 23rd Annual Global Healthcare Conference. Analyst ratings have varied, with a consensus rating of "Hold".

While Definitive Healthcare provides solutions to help clients predict healthcare demand trends, there is no explicit information stating that the demand for Definitive Healthcare's own products and services is seasonal. The company's subscription-based business model generally aims for recurring revenue. The availability of tools to analyze "DH Monthly Seasonality" for its stock performance suggests that there might be seasonal patterns in investor behavior or other external factors affecting the company.

Definitive Healthcare Corp. is a leading provider of healthcare commercial intelligence, operating within the Healthcare sector and the Health Information Services industry. The company offers a comprehensive SaaS platform designed to provide accurate information on the U.S. healthcare ecosystem, assisting clients in making data-driven strategic decisions. Its major products include HospitalView, PhysicianView, PhysicianGroupView, ConnectedCareView, LongTermCareView, ClinicView, ImagingView, SurgeryCenterView, SpecialtyRxView, Monocl ExpertInsight, Atlas All-Payor & Prescription Claims, and Market Forecast. The company's business model is primarily subscription-based.

Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts, and primarily derives its revenue from the United States. The company is exploring opportunities for geographic expansion beyond the United States, targeting international markets with similar healthcare dynamics.

Definitive Healthcare has received positive recognition for its workplace culture, being named a "2025 Best Places to Work in Boston by Built In" and publishing its 2023 Sustainability Report. However, some employee reviews indicate mixed sentiments, with concerns about disorganization and new leadership. The company has faced challenges such as elevated customer churn rates and lower-than-achievable renewal rates, leading to a "Sell" rating from some analysts.

Definitive Healthcare Corp.'s stock ownership is a mix of institutional, insider, and public/individual investors. Institutional investors own approximately 69.37% to 74.63% of the stock, insiders own 8.74%, and public companies and individual investors own 5.26% to 16.63%. David Mussafer owns the most shares of Definitive Healthcare Corp.